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Background and Purpose Although onset-to-treatment time is associated with early clinical 
recovery in acute ischemic stroke (AIS) patients treated with intravenous tissue plasminogen 
activator (tPA), the effect of the timing of tPA-induced recanalization on functional outcomes 
remains debatable.
Methods We conducted a multicenter, prospective observational cohort study to determine 
whether early (within 1-hour from tPA-bolus) complete or partial recanalization assessed during 
2-hour real-time transcranial Doppler monitoring is associated with improved outcomes in patients 
with proximal occlusions. Outcome events included dramatic clinical recovery (DCR) within 2 and 
24-hours from tPA-bolus, 3-month mortality, favorable functional outcome (FFO) and functional 
independence (FI) defined as modified Rankin Scale (mRS) scores of 0–1 and 0–2 respectively.
Results We enrolled 480 AIS patients (mean age 66±15 years, 60% men, baseline National 
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Introduction
Intravenous thrombolysis (IVT) with tissue plasminogen activa-
tor (tPA) remains the only approved systemic therapy for acute 
ischemic stroke (AIS), with onset-to-treatment time being di-
rectly associated with improved short-term and long-term 
clinical outcomes.1-3 Since recanalization following IVT is di-
rectly associated with early clinical recovery,4 it is logical to as-
sume that faster recanalization is the mechanism why earlier 
treatment with tPA can lead to improved 3-month functional 
outcomes.5-8 However, the potential correlation between onset-
to-tPA treatment time and elapsed time between tPA-bolus 
and beginning of recanalization has not been established yet. 
Furthermore, the influence of timing of tPA-induced recanali-
zation on functional outcomes and risk of symptomatic intra-
cerebral hemorrhage (sICH) in AIS remains debatable.
In view of these considerations, we designed the ‘PROspec-
tive multi-national Combined Lysis of Thrombus in Brain Isch-
emia Using Transcranial Ultrasound and Systemic tPA (CLOT-
BUST) collaboration on reperfusion therapies for stroke’ (CLOT-
BUST-PRO)9 that sought to determine whether early recanali-
zation (within 1-hour from tPA-bolus), assessed with real-time 
transcranial Doppler (TCD) monitoring, is independently associ-
ated with improved 3-month outcomes in AIS patients with 
proximal intracranial arterial occlusions. We also investigated 
the association between the elapsed time between symptom 
onset and tPA-bolus with the elapsed time between tPA-bolus 
and beginning of recanalization. We hypothesized the early tPA 
delivery may result to swift recanalization which in turn may 
translate into better clinical outcomes.
Methods
Study design
We conducted this prospective, open-label, observational co-
hort study in 12 participating tertiary care stroke centers in 
North America, South America, Europe, and Asia. The rationale 
for the study, design details, and eligibility criteria have been 
previously published.9 Exclusion criteria together with other 
detail on the methodology of our trial are available in the Sup-
plementary Material.
Study population 
We included patients with AIS attributable to a proximal intra-
cranial occlusion eligible for IVT, who presented within 4.5 
hours to the participating sites.9 The study was approved by the 
Ethics Committees and the Institutional Review Boards of par-
ticipating Institutions as previously described. All patients or 
their substitute decision-makers provided written consent prior 
to participation.9 
Insonation protocol
All eligible patients received continuous 2-MHz TCD or tran-
scranial color-coded duplex (TCCD) assessment of recanaliza-
tion up to 2 hours following tPA-bolus by experienced sonog-
raphers. The duration of continuous TCD monitoring varied be-
tween 60 and 120 minutes, because if there was no ultrasono-
graphic evidence of recanalization within 60 minutes from 
tPA-bolus and the patient was considered by the treating phy-
sician as a candidate for additional revascularization therapies 
(intra-arterial thrombolysis or mechanical thrombectomy), TCD 
monitoring was discontinued and an additional TCD evaluation 
was performed at the end of endovascular reperfusion thera-
Institutes of Health Stroke Scale score 15). Patients with early recanalization (53%) had 
significantly (P<0.001) higher rates of DCR at 2-hour (54% vs. 10%) and 24-hour (63% vs. 22%), 
3-month FFO (67% vs. 28%) and FI (81% vs. 39%). Three-month mortality rates (6% vs. 17%) and 
distribution of 3-month mRS scores were significantly lower in the early recanalization group. After 
adjusting for potential confounders, early recanalization was independently associated with higher 
odds of 3-month FFO (odds ratio [OR], 6.19; 95% confidence interval [CI], 3.88 to 9.88) and lower 
likelihood of 3-month mortality (OR, 0.34; 95% CI, 0.17 to 0.67). Onset to treatment time 
correlated to the elapsed time between tPA-bolus and recanalization (unstandardized linear 
regression coefficient, 0.13; 95% CI, 0.06 to 0.19).
Conclusions Earlier tPA treatment after stroke onset is associated with faster tPA-induced 
recanalization. Earlier onset-to-recanalization time results in improved functional recovery and 
survival in AIS patients with proximal intracranial occlusions.
Keywords Thrombolysis; Stroke; Reperfusion; Outcomes
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pies. This therapeutic approach towards endovascular reperfu-
sion therapies was based on the lack of available randomized-
controlled clinical trial data supporting the clinical efficacy of 
mechanical thrombectomy at the time of study design and pa-
tient enrollment (2008 to 2014). 
In patients with clinical deterioration following initial im-
provement within the first 24 hours from symptom onset, an 
additional TCD recording was performed to assess the presence 
of delayed re-occlusion.
TCD findings were interpreted using previously validated cri-
teria, including the thrombolysis in brain ischemia (TIBI) flow 
grade definitions.10,11 
Outcomes
The main hypothesis and primary efficacy outcome of the 
study was to determine whether early tPA-induced partial or 
complete recanalization, achieved during the first hour of TCD 
monitoring following tPA-bolus, was independently associated 
with more favorable early and long term clinical outcomes. The 
primary outcome of interest was the difference in the favor-
able functional outcome (FFO; defined modified Rankin Scale 
[mRS] score of 0–1 at 3-month) rates in patients with early 
complete or partial recanalization compared to those with per-
sisting occlusion at 1-hour TCD monitoring. The exact time of 
the beginning, duration, timing and amount of recanalization 
and re-occlusion were recorded for all patients. Beginning of 
recanalization was marked as the time point in which at least 
1 point improvement in TIBI score was noticed during the TCD 
monitoring.12 A table summarizing the definitions of the afore-
mentioned outcomes is provided in the Supplementary Table 1.
Early clinical outcome was assessed with the rates of dra-
matic clinical recovery (DCR), defined by a change of equal or 
more than 10 points in the National Institutes of Health Stroke 
Scale (NIHSS) or total NIHSS score of less or equal to 3 within 
2 and 24 hours after tPA-bolus.11 Finally, we prospectively fol-
lowed all patients up to 3 months to record also functional in-
dependence (FI; defined as 3-month mRS of 0–2) and deaths 
from any cause during the 3-month follow-up period.
sICH with clinical worsening (≥4 NIHSS points) that in the 
opinion of the treating physician was causatively and tempo-
rally related to neurological deterioration during the first 24 
hours following tPA infusion,9 was considered as the primary 
safety endpoint. 
For all patients, serial assessments on NIHSS scores were ob-
tained at baseline (pre-tPA-bolus), within 10 minutes of the be-
ginning of recanalization or re-occlusion, at the end of TCD 
monitoring and at 24-hour after symptom onset by vascular 
neurologists certified in the NIHSS scoring.9 Functional outcome 
was evaluated at 3-month by the on-site investigators (certified 
in the assessment of mRS) who were unaware of TCD monitoring 
findings. All radiological examinations were independently eval-
uated by institutional radiologists/neuroradiologists who were 
blinded to both TCD findings and patient clinical data. 
Statistical analyses
We enrolled 480 patients to identify at least 120 cases of early 
complete recanalization and have power of 82.4% to detect a 
statistically significant difference of at least 15% in FI rates at 
3-month between patients with early recanalization and per-
sisting occlusion/delayed recanalization.5 Dichotomous vari-
ables were presented with their absolute values and corre-
sponding percentages, while continuous variables were pre-
sented as mean values with their corresponding standard devi-
ations for normally distributed data, or median values with 
their corresponding interquartile ranges (IQRs) when distribu-
tions were skewed. We compared baseline characteristics and 
outcomes between patients with complete or partial recanali-
zation and those with persisting occlusion with the Pearson’s 
chi-square or Mann-Whitney-Wilcoxon test where appropri-
ate. The distributions on the mRS-score between groups at 
3-month follow-up were compared with the Cochran-Mantel-
Haenszel test, as previously described.13
Univariable and multivariable logistic regression analyses were 
performed to evaluate the associations between baseline char-
acteristics and outcomes (sICH, 3-month FFO and mortality). We 
also performed additional sensitivity analyses after dichotomiz-
ing time from symptom onset to beginning of recanalization us-
ing the variable’s observed median value as threshold (>178 and 
≤178 minutes) and persisting occlusion set as reference category. 
Only the factors proven significant (P<0.05) at the univariable 
analyses were entered into the multivariable models. We also 
performed a post hoc subgroup analysis by including only pa-
tients with middle cerebral artery (MCA) occlusions.
Apart from the analysis in the total sample, a nested analysis 
(univariable and multivariable logistic regression analysis) was 
performed in the subgroup of patients with sustained complete 
or partial early recanalization at the end of 2-hour TCD-moni-
toring. The same approach was followed as in the total sample, 
with the exception of time from symptom onset to the begin-
ning of recanalization, which was treated in increments of 30 
minutes. In this subgroup of patients, the potential correlations 
between onset-to-treatment time (elapsed time between 
symptom onset and tPA-bolus) and baseline characteristics, in-
cluding elapsed time between tPA-bolus and beginning of re-
canalization, were assessed with simple and multiple regres-
sion analyses, adjusting for potential confounders. Statistical 
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analyses were performed with STATA/SE version 13 (Stata Corp, 
College Station, TX, USA).
Data availability statement
De-identified patient dataset will be made available upon rea-
sonable request from the corresponding author.
Results
The predetermined sample size of 480 AIS patients (mean age 
66±15 years, 60% men) with proximal intracranial occlusions, 
who underwent continuous 2-hour TCD-monitoring following 
tPA-bolus, was enrolled during a 7-year period (January 2008 
to December 2014) from 12 participating tertiary care stroke 
centers from North America (n=2), South America (n=1), Eu-
rope (n=7), and Asia (n=2). The complete list of participating 
centers is available in the Supplementary Material. The median 
admission NIHSS-score was 15 points (IQR, 10 to 19) and the 
median onset to treatment time was 140-minute (IQR, 116 to 
170). Baseline characteristics of the study population are pre-
sented in Supplementary Table 2. The distribution of proximal 
intracranial occlusions was as follows: M1-MCA 48% (n=231), 
M2-MCA 29% (n=141), terminal internal carotid artery (ICA) 
9% (n=44), tandem ICA/MCA 5% (n=24), basilar artery 7% 
(n=61), intracranial vertebral artery 0.2% (n=1), and posterior 
cerebral artery 1% (n=6). No patient was lost during the 
3-month follow-up.
Complete or partial recanalization was detected in 180 
(38%) and 71 (15%) patients at 1-hour TCD monitoring, re-
spectively, and in 211 (44%) and 90 (19%) patients at the 
2-hour TCD-monitoring point, respectively. Sustained complete 
or partial recanalization was achieved in 201 (42%) and 85 
(18%) patients, respectively at the end of 2-hour TCD-monitor-
ing, while re-occlusion was documented in 18 cases (4%). The 
median onset to recanalization and the median bolus to reca-
nalization times were 178-minute (IQR, 145 to 214) and 
24-minute (IQR, 22 to 53), respectively. Comparisons of the 
baseline characteristics between patients with persisting occlu-
sion or any (partial or complete) recanalization within the first 
hour of TCD monitoring are presented in Table 1. Patients with 
complete or partial early recanalization during the first hour of 
TCD-monitoring as compared to patients with persisting occlu-
sion/delayed recanalization were younger (63±14 years vs. 
69±15 years, P<0.001), more likely to be men (65% vs. 55%, 
P=0.048) and had lower prevalence of isolated ICA or tandem 
ICA/MCA occlusion (10% vs. 19%, P=0.006). Patients with early 
recanalization had shorter median onset-to-treatment times 
(135-minute vs. 145-minute, P=0.002), higher pre-treatment 
Table 1. Baseline characteristics and outcomes of study population (n=480) 














Age (yr) 63±14 69±15 <0.001*
Male sex 162 (65) 127 (55) 0.048†
NIHSS-score (point) 14 (9–19) 15 (10–20) 0.112*
Hypertension 164 (65) 161 (71) 0.217†
Diabetes mellitus 60 (24) 56 (25) 0.867†
Atrial fibrillation 69 (27) 76 (33) 0.174†
Hypercholesterolemia 108 (43) 78 (35) 0.073†
Coronary artery disease 64 (25) 55 (24) 0.707†
Baseline TIBI score 0–1 138 (55) 113 (49) 0.217†
Isolated ICA or tandem 
ICA/MCA occlusion
25 (10) 43 (19) 0.006†
Systolic blood pressure 
before tPA-bolus  
(mm Hg) 
160±26 154±26 0.022*
Diastolic blood pressure 
before tPA-bolus  
(mm Hg) 
90±15 85±16 <0.001*
Serum glucose before 
tPA-bolus (mg/dL) 
130±53 135±47 0.140*
Time from symptom on-
set to tPA-bolus (min)
135 (110–165) 145 (120–180) 0.002*
Endovascular reperfusion 
therapies




6 (2) 13 (6) 0.065 †
Dramatic clinical recovery 
at 2-hr§
129 (54) 21 (10) <0.001†
Dramatic clinical recovery 
at 24-hr∥
155 (63) 46 (22) <0.001†
3-mo favorable function-
al outcome mRS 0–1
169 (67) 63 (28) <0.001†
3-mo functional inde-
pendence mRS 0–2 
203 (81) 89 (39) <0.001†
3-mo mortality 16 (6) 39 (17) <0.001†
3-mo mRS score 1 (0–2) 3 (1–5) <0.001¶
Values are presented as mean±standard deviation, number (%), or median 
(interquartile range). 
TCD, transcranial Doppler; NIHSS, National Institutes of Health Stroke 
Scale; TIBI, thrombolysis in brain ischemia; ICA, internal carotid artery; 
MCA, middle cerebral artery; tPA, tissue plasminogen activator; mRS, mod-
ified Rankin Scale.
*P-value derived from Mann-Whitney-Wilcoxon test for independent sam-
ples; †P-value derived from Pearson’s chi-square; ‡P-value derived from Fish-
er’s exact test; §Missing data on 2-hour NIHSS for 27 patients; ∥Missing 
data on 24-hour NIHSS for 24 patients; ¶P-value derived from Cochran–
Mantel–Haenszel test.
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systolic (160±26 mm Hg vs. 154±26 mm Hg, P=0.022), and di-
astolic blood pressure levels (90±15 mm Hg vs. 85±16 mm Hg, 
P<0.001). sICH rates were not different between patients with 
early complete or partial recanalization and patients with per-
sisting occlusion (2% vs. 6%, P=0.065). Patients with early re-
canalization had significantly (P<0.001) higher rates of DCR at 
2-hour (54% vs. 10%) and 24-hour (63% vs. 22%), 3-month 
FFO (67% vs. 28%) and 3-month FI (81% vs. 39%). Three-
month mortality rates (6% vs. 17%) and distribution of 
3-month mRS scores (1 [0 to 2] vs. 3 [1 to 5]) were significant-
ly lower in the early recanalization subgroup. The respective 
comparisons of the baseline characteristics and outcomes be-
tween patients with persisting occlusion and those with any 
(partial or complete) recanalization within 2 hours of TCD mon-
itoring are available in Supplementary Table 3.
In multivariable analyses adjusting for potential confounders, 
early complete or partial recanalization within the first hour 
after tPA-bolus was independently associated with higher odds 
of 3-month FFO (odds ratio [OR], 6.19; 95% confidence inter-
val [CI], 3.88 to 9.88; P<0.001) (Table 2) and lower likelihood of 
3-month mortality (OR, 0.34; 95% CI, 0.17 to 0.67; P=0.002) 
(Table 3) compared to delayed recanalization or persisting oc-
clusion.
These associations were reproduced in our sensitivity analyses 
stratifying patients with complete or partial recanalization 
during the 2-hour TCD monitoring by the median of symptom 
onset to recanalization time (178 minutes). More specifically, a 
more pronounced beneficial effect on 3-month FFO was docu-
mented in patients with initiation of recanalization within the 
first 178 minutes after symptom onset (OR [vs. the reference 
group of persisting occlusion], 14.70; 95% CI, 7.90 to 27.33; 
P<0.001) (Table 4) compared to patients with a more delayed re-
canalization after 178 minutes from symptom onset (OR [vs. the 
reference group of persisting occlusion], 6.72; 95% CI, 3.78 to 
11.92; P<0.001) (Table 4). An independent association with lower 
likelihood of 3-month mortality was detected for both groups of 
early (≤178-minute from symptom onset; OR, 0.37; 95% CI, 0.16 
to 0.85; P=0.018) or delayed (>178-minute from symptom on-
set; OR, 0.22; 95% CI, 0.10 to 0.51; P<0.001) recanalization ver-
sus persisting occlusions (Table 5). In the subgroup analysis of 
patients with MCA occlusions (n=374) similar differences in the 
outcomes of interest were documented between patients with 
early complete or partial recanalization compared to patients 
with delayed recanalization or persisting occlusion (Supplemen-
tary Table 4). This subgroup analysis confirmed the associations 
documented in our primary analysis including all patients.
In the nested subgroup analysis (Supplementary Table 5) of 
patients with sustained complete or partial recanalization at 
the end of 2-hour TCD-monitoring (n=301), an independent 
association was detected between increasing elapsed time 
from symptom onset to the beginning of recanalization and 
reduced odds of 3-month FFO (OR per 30-minute increase, 
Table 2. Association of early (within 1-hour from tPA-bolus) recanalization with 3-month favorable functional outcome in the study population (n=480)
Variable
Univariable analysis Multivariable analysis
Odds ratio (95% CI) P Odds ratio (95% CI) P
Age (/1 yr increase) 0.96 (0.95–0.97) <0.001 0.97 (0.95–0.99) 0.001
Male sex 1.64 (1.13–2.37) 0.009 1.70 (1.06–2.71) 0.027
NIHSS-score (/1 point increase) 0.86 (0.83–0.89) <0.001 0.85 (0.82–0.89) <0.001
Hypertension 0.64 (0.44–0.95) 0.026 1.18 (0.71–1.99) 0.518
Diabetes mellitus 0.83 (0.54–1.26) 0.372 -
Atrial fibrillation 0.73 (0.49–1.07) 0.108 -
Hypercholesterolemia 1.08 (0.75–1.56) 0.687 -
Coronary artery disease 0.98 (0.65–1.48) 0.913 -
Baseline TIBI score 0–1 0.64 (0.45–0.92) 0.015 1.05 (0.64–1.72) 0.842
Isolate ICA or tandem ICA/MCA occlusion 0.30 (0.17–0.55) <0.001 0.53 (0.26–1.09) 0.083
Systolic blood pressure before tPA-bolus (/10 mm Hg increase) 0.96 (0.90–1.03) 0.275 -
Diastolic blood pressure before tPA-bolus (/10 mm Hg increase) 0.98 (0.87–1.11) 0.749 -
Mean serum glucose before tPA-bolus (/10 mg/dL increase) 0.96 (0.93–1.00) 0.050 -
Time from symptom onset to tPA-bolus (/10 min increase) 0.97 (0.93–1.01) 0.128 -
Early recanalization 5.43 (3.67–8.04) <0.001 6.19 (3.88–9.88) <0.001
Endovascular reperfusion therapies 2.18 (0.65–7.33) 0.209 - -
tPA, tissue plasminogen activator; CI, confidence interval; NIHSS, National Institutes of Health Stroke Scale; TIBI, thrombolysis in brain ischemia; ICA, internal 
carotid artery; MCA, middle cerebral artery. 
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Table 3. Association of early (within 1-hour from tPA-bolus) recanalization with 3-month mortality in the study population (n=480)
Variable
Univariable analysis Multivariable analysis
Odds ratio (95% CI) P Odds ratio (95% CI) P
Age (/1 yr increase) 1.05 (1.03–1.08) <0.001 1.04 (1.01–1.06) 0.003
Male sex 0.65 (0.37–1.14) 0.131 -
NIHSS-score (/1 point increase) 1.16 (1.11–1.22) <0.001 1.16 (1.10–1.22) <0.001
Hypertension 1.07 (0.58–1.96) 0.834 -
Diabetes mellitus 1.47 (0.79–2.72) 0.220 -
Atrial fibrillation 1.79 (1.00–3.17) 0.048 1.16 (0.60–2.24) 0.649
Hypercholesterolemia 0.85 (0.47–1.54) 0.592 -
Coronary artery disease 1.72 (0.94–3.12) 0.078 -
Baseline TIBI score 0–1 1.20 (0.68–2.12) 0.521 -
Isolated ICA or tandem ICA/MCA occlusion 2.35 (1.20–4.59) 0.013 1.32 (0.63–2.77) 0.462
Systolic blood pressure before tPA-bolus (/10 mm Hg increase) 0.93 (0.84–1.04) 0.195 -
Diastolic blood pressure before tPA-bolus (/10 mm Hg increase) 0.89 (0.74–1.07) 0.221 -
Mean serum glucose before tPA-bolus (/10 mg/dL increase) 1.02 (0.96–1.07) 0.536 -
Time from symptom onset to tPA-bolus (/10 min increase) 1.00 (0.94–1.06) 0.923 -
Early recanalization 0.33 (0.18–0.61) <0.001 0.34 (0.17–0.67) 0.002
Endovascular reperfusion therapies Not estimable* >0.999† -
tPA, tissue plasminogen activator; CI, confidence interval; NIHSS, National Institutes of Health Stroke Scale; TIBI, thrombolysis in brain ischemia; ICA, internal 
carotid artery; MCA, middle cerebral artery.
*Not estimable due to lack of events (deaths) in the subgroup of patients receiving endovascular treatment; †P-value derived from Fisher’s exact test.
Table 4. Association of elapsed time between symptom onset and beginning of recanalization with 3-month favorable functional outcome in the study popu-
lation (n=480)
Variable
Univariable analysis Multivariable analysis
Odds ratio (95% CI) P Odds ratio (95% CI) P
Age (/1 yr increase) 0.96 (0.95–0.97) <0.001 0.97 (0.95–0.99) 0.002
Male sex 1.64 (1.13–2.37) 0.009 1.55 (0.96–2.52) 0.076
NIHSS-score (/1 point increase) 0.86 (0.83–0.89) <0.001 0.85 (0.81–0.89) <0.001
Hypertension 0.64 (0.44–0.95) 0.026 1.33 (0.77–2.31) 0.303
Diabetes mellitus 0.83 (0.54–1.26) 0.372 -
Atrial fibrillation 0.73 (0.49–1.07) 0.108 -
Hypercholesterolemia 1.08 (0.75–1.56) 0.687 -
Coronary artery disease 0.98 (0.65–1.48) 0.913 -
Baseline TIBI score 0–1 0.64 (0.45–0.92) 0.015 1.21 (0.73–2.01) 0.460
Isolate ICA or tandem ICA/MCA occlusion 0.30 (0.17–0.55) <0.001 0.57 (0.27–1.21) 0.143
Systolic blood pressure before tPA-bolus (/10 mm Hg increase) 0.96 (0.90–1.03) 0.275 -
Diastolic blood pressure before tPA-bolus (/10 mm Hg increase) 0.98 (0.87–1.11) 0.749 -
Mean serum glucose before tPA-bolus (/10 mg/dL increase) 0.96 (0.93–1.00) 0.050 -
Time from symptom onset to tPA-bolus (/10 min increase) 0.97 (0.93–1.01) 0.128 -
Endovascular reperfusion therapy 2.18 (0.65, 7.33) 0.209 - -
Time from symptom onset to beginning of recanalization
Persisting occlusion (reference category) ≤178 min 13.23 (7.82–22.39) <0.001 14.70 (7.90–27.33) <0.001
Persisting occlusion (reference category) >178 min 5.55 (3.39–9.10) <0.001 6.72 (3.78–11.92) <0.001
CI, confidence interval; NIHSS, National Institutes of Health Stroke Scale; TIBI, thrombolysis in brain ischemia; ICA, internal carotid artery; MCA, middle cere-
bral artery; tPA, tissue plasminogen activator.
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0.84; 95% CI, 0.73 to 0.97; P=0.015) (Figure 1). Moreover, 
among all baseline characteristics only onset-to-treatment 
time correlated positively to the elapsed time between tPA-bo-
lus and beginning of recanalization (unstandardized linear re-
gression coefficient, 0.13; 95% CI, 0.06 to 0.19; P<0.001) (Fig-
ure 2) in the subgroup of patients with complete or partial re-
canalization at the end of TCD-monitoring (Supplementary Ta-
ble 6). In a post hoc sensitivity analysis after adjusting for pre-
defined potential confounders (baseline age, NIHSS score, 
presence of tandem occlusion, and endovascular treatment), a 
similar correlation of elapsed time from symptom onset to 
tPA-bolus with elapsed time from tPA-bolus to the beginning 
of recanalization documented (unstandardized linear regres-
sion coefficient, 0.13; 95% CI, 0.06 to 0.20; P<0.001).
We detected no association between elapsed time from symp-
tom onset and beginning of recanalization with sICH in multi-
variable analyses of the study population (Supplementary Table 
7) and in the subgroup of patients with sustained complete or 
partial recanalization (n=301) at the end of TCD-monitoring 
(Supplementary Table 8). Three-month mortality was not associ-
ated with the timing of tPA-induced recanalization in the group 
of patients with sustained complete or partial recanalization at 
the end of 2-hour TCD-monitoring (Supplementary Table 9).
Figure 1. Frequency of favorable functional outcome by elapsed time be-
tween symptom onset and the beginning of recanalization, as predicted by 
unadjusted analysis in patients with sustained complete or partial recanali-
zation at the end of transcranial Doppler-monitoring (n=301). The recana-
lization cohort (including patients with complete or partial sustained re-
canalization) was divided into groups of about 30 on the basis of deciles in 
the time to recanalization. The red circles show the proportion with favor-
able functional outcome and mean time to recanalization in each group, 
and the red horizontal lines depict the range of time included in that group. 
The solid curve shows the model results from the logistic regression analy-
sis, with 95% confidence interval prediction bands shown in dashed curves. 
Favorable functional outcome was defined as a modified Rankin Scale 
score of ≤1.
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Table 5. Association of elapsed time between symptom onset and beginning of recanalization with 3-month mortality in the study population (n=480)
Variable
Univariable analysis Multivariable analysis
Odds ratio (95% CI) P Odds ratio (95% CI) P
Age (/1 yr increase) 1.05 (1.03–1.08) <0.001 1.04 (1.01–1.06) 0.002
Male sex 0.65 (0.37–1.14) 0.131 -
NIHSS-score (/1 point increase) 1.16 (1.11–1.22) <0.001 1.16 (1.10–1.23) <0.001
Hypertension 1.07 (0.58–1.96) 0.834 -
Diabetes mellitus 1.47 (0.79–2.72) 0.220 -
Atrial fibrillation 1.79 (1.00–3.17) 0.048 1.21 (0.62–2.34) 0.574
Hypercholesterolemia 0.85 (0.47–1.54) 0.592 -
Coronary artery disease 1.72 (0.94–3.12) 0.078 -
Baseline TIBI score 0–1 1.20 (0.68–2.12) 0.521 -
Isolate ICA or tandem ICA/MCA occlusion 2.35 (1.20–4.59) 0.013 1.26 (0.59–2.70) 0.546
Systolic blood pressure before tPA-bolus (/10 mm Hg increase) 0.93 (0.84–1.04) 0.195 -
Diastolic blood pressure before tPA-bolus (/10 mm Hg increase) 0.89 (0.74–1.07) 0.221 -
Mean serum glucose before tPA-bolus (/10 mg/dL increase) 1.02 (0.96–1.07) 0.536 -
Time from symptom onset to tPA-bolus (/10 min increase) 1.00 (0.94–1.06) 0.923 -
Endovascular reperfusion therapy Not estimable* >0.999† - -
Time from symptom onset to beginning of recanalization
Persisting occlusion (reference category) ≤178 min 0.28 (0.14–0.59) 0.001 0.37 (0.16–0.85) 0.018
Persisting occlusion (reference category) >178 min 0.26 (0.12–0.55) 0.001 0.22 (0.10–0.51) <0.001
CI, confidence interval; NIHSS, National Institutes of Health Stroke Scale; TIBI, thrombolysis in brain ischemia; ICA, internal carotid artery; MCA, middle cere-
bral artery; tPA, tissue plasminogen activator.
*Not estimable due to lack of events (deaths) in the subgroup of patients receiving endovascular treatment; †P-value derived from Fisher’s exact test.
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Discussion
Our prospective observational study showed that faster tPA-in-
duced recanalization represents the link between shorter on-
set-to-treatment time and improved 3-month functional out-
comes in AIS patients with proximal intracranial occlusions. 
Shorter onset-to-tPA-bolus time was associated with more 
prompt recanalization because of shorter tPA-bolus-to-recan-
alization time. Elapsed time between symptom onset and be-
ginning of recanalization was an independent predictor of 
3-month functional outcome among patients who achieved 
sustained early complete or partial recanalization. Finally, de-
layed recanalization was not related to the risk of sICH in the 
whole study population. Our study supports ultra-fast delivery 
of tPA after patient arrival to hospital. Taking also into account 
that the vast majority of complete or partial vessel recanaliza-
tions were found to occur within 1-hour from tPA-bolus and 
that very few patients recanalized after 1-hour from tPA-bolus, 
our results also provide unflinching support the strategy of not 
delaying endovascular procedures in cases of persisting occlu-
sion after tPA administration. Therefore, our results on the as-
sociation of shorter onset-to-treatment time with faster in-
duced recanalization and improved 3-month functional out-
comes, should not only apply for systemic tPA treatment, but 
also for endovascular therapies and align with the continuous 
efforts for reduction of onset-to-groin puncture and groin 
puncture-to recanalization times. Although TCD can be used as 
a very reliable tool for continuous, real-time assessment of 
vessel recanalization, in the era of mechanical thrombectomy 
it could only be useful in case of other imaging unavailability, 
and should not delay any systemic or endovascular therapies 
when employed for clinical or research purposes.
We detected sustained complete early recanalization in 42% 
of patients within 2 hours after tPA-bolus and DCR in 50% at 
the end of TCD-monitoring. Although the rates of tPA-induced 
recanalization are higher in our cohort than those reported for 
patients with large vessel occlusions (LVOs) following treat-
ment with systemic thrombolysis,14,15 it should be highlighted 
that they are in accordance with the results from the CLOT-
BUST trial,11 reporting sustained complete recanalization in 
46% and DCR in 44% of the patients receiving tPA administra-
tion coupled with continuous TCD-monitoring.11 Our findings 
are also in line with a longitudinal cohort of consecutive AIS 
patients treated with IVT that reported sustained recanaliza-
tion in 51% of the study population at the end of the 2-hour 
TCD-monitoring.16 Finally, the sICH rate in our population (4%) 
was comparable to the treatment arm of the recently pub-
lished multicenter, double-blind, phase 3, randomized con-
trolled trial on the safety and efficacy of 2 hours continuous 
transcranial ultrasound insonation coupled with tPA treatment 
in AIS patients (3%), providing further evidence of no increase 
in the sICH risk with TCD insonation.17
The timing of tPA-induced recanalization after stroke onset 
was a strong predictor of clinical outcomes in the whole study 
population and among patients with sustained recanalization at 
the end of TCD-monitoring. This observation is corroborated by 
the findings of a retrospective, single-center study of 508 AIS 
patients treated with IVT (54% with proximal intracranial occlu-
sions).18 The investigators reported an inverse relationship be-
tween the probability of early recanalization, evaluated by TCD 
at 1-hour following the end of tPA infusion and elapsed time 
from symptom onset.18 However, no association between onset-
to-treatment and tPA-bolus to initiation of recanalization time 
was found.18 The inverse relationship between onset-to-treat-
ment time and the rate of tPA-induced recanalization has also 
been identified in another study of 102 AIS patients with proxi-
mal intracranial occlusions treated with IVT.19 Early recanaliza-
tion at the end of alteplase infusion (1-hour after tPA-bolus) was 
determined using magnetic resonance angiography (MRA). The 
investigators of this study reported that tPA administration 
within 130 minutes from symptom onset was independently as-
sociated with a 3-fold higher likelihood of complete recanaliza-
tion at the end of tPA infusion.19 Finally, our results are also in 
accordance with an experimental study protocol supporting that 
early administration of tPA after stroke onset is independently 
associated with better thrombus resolution.20
Figure 2. Correlation of elapsed time between symptom onset and tissue 
plasminogen activator (tPA)-bolus (onset to treatment time) with elapsed 
time between tPA-bolus to the beginning of recanalization in patients with 
sustained complete or partial recanalization at the end of transcranial 
Doppler-monitoring (n=301). The 95% confidence interval (CI) forecast 
bands are also presented. The correlation between the two time intervals 
was statistically significant (unstandardized linear regression coefficient, 
0.13; 95% CI, 0.06 to 0.19; P<0.001).
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The main study finding, that the beneficial effect of tPA-in-
duced recanalization on clinical outcomes of AIS patients with 
proximal intracranial occlusions are time-dependent (16% de-
crease in the likelihood of FFO for every 30-minute delay in the 
elapsed time between symptom onset and initiation of recana-
lization) parallel the recent experience with mechanical throm-
bectomy in AIS patients with LVOs.21-27 Both randomized-con-
trolled and observational data have highlighted a time depen-
dency of the beneficial effect of endovascular reperfusion 
therapies in AIS due to LVO.21-27 More specifically, in a pre-
specified analysis of the Interventional Management of Stroke 
III (IMS III) trial, every 30-minute delay in angiographic reper-
fusion of AIS patients with LVO was associated with a 12% 
decrease in the likelihood of 3-month FI on multivariable anal-
yses adjusting for potential confounders.26 Similarly, the Highly 
Effective Reperfusion Evaluated in Multiple Endovascular 
Stroke Trials (HERMES) collaborators have recently reported 
that each 1-hour delay to reperfusion was associated with a 
19% reduction in the odds of 3-month FI among LVO patients 
who achieved reperfusion following mechanical thrombectomy 
and standard therapy.27
To the best of our knowledge, CLOTBUST-PRO is the first 
prospective, international multicenter observational study, with 
adequate statistical power, a predefined protocol and no miss-
ing follow-up evaluation at 3 months, which provides real-
time information on arterial recanalization dependency with 
shorter symptom-onset-to-treatment time linking it to 
3-month functional outcomes. The correlation between earlier 
onset to treatment time and shorter elapsed time between 
tPA-bolus and initiation of recanalization has not been previ-
ously reported. Our results provide further support to the asso-
ciation of ultra-early tPA administration with favorable out-
comes3 and highlight the potential role of mobile stroke units 
in prompt tPA administration in this ultra-early time window.28
Certain limitations of the present study need to be acknowl-
edged. First, per study protocol, no screening log was provided 
from the participating centers and thus the percentage of ex-
cluded patients, with corresponding reasons for exclusion (e.g., 
insufficient temporal window or tPA contraindications) is not 
available. However, it should be highlighted that included pa-
tients from all institutions were consecutive and thus we con-
sider the possibility of selection bias negligible. Second, we 
evaluated arterial recanalization only within the first 2 hours 
of treatment initiation. However, per our study protocol all pa-
tients experiencing clinical deterioration during the first 24 
hours from symptom onset received an additional TCD record-
ing. Third, in patients with no ultrasonographic evidence of 
successful recanalization at 60-minute after tPA initiation, TCD 
monitoring was discontinued and they were treated with addi-
tional revascularization therapies, if available at the participat-
ing centers. Although the number of patients receiving addi-
tional endovascular reperfusion therapies was limited (2% of 
the study population), the duration of monitoring was not 
consistent among the whole study population. Finally, determi-
nation of recanalization status using TCD-monitoring is chal-
lenging and highly operator-dependent. Although no central 
adjudication of TCD recording was available, it should be noted 
that the centers participating in CLOTBUST-PRO recruited 
skilled and experienced sonographers implementing predefined 
ultrasound criteria that have been shown to accurately (>80%) 
predict complete recanalization in real-time compared to digi-
tal subtraction angiography.29 Moreover, we do not have data 
on the imaging modalities used to screen proximal intracranial 
occlusions and therefore we were not able to assess potential 
discrepancies between TCD and computed tomography angiog-
raphy/MRA findings.
On the other hand, certain strengths of the present study 
may also be acknowledged. CLOTBUST-PRO represents a pro-
spective, international adequately powered observational study 
that sought to assess and establish the association of the 
speed of tPA-induced recanalization with shorter symptom-
onset-to-treatment time using a predefined previously pub-
lished protocol.9 To the best of our knowledge, we consider 
that this association represents the causative mechanism that 
accounts for the improved functional outcomes documented 
with earlier tPA delivery.1,2 The former association has previ-
ously been established in AIS patients receiving endovascular 
reperfusion therapies21-27 but has never been documented in 
AIS patients receiving systemic thrombolysis, since TCD repre-
sents the only imaging modality that can assess recanalization 
in real-time in patients receiving treatment with IVT.30
Conclusions
In conclusion, our observational cohort study provides observa-
tional evidence that faster tPA delivery is associated with earlier 
tPA-induced recanalization, which in turn results in improved 
functional recovery and survival in AIS patients with proximal 
intracranial occlusions. Our study further underscores the need 
to arrange acute stroke services in ways that shortest possible 
onset-to-arrival and arrival-to-tPA-bolus time be achieved. 
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Supplementary methods
Per study protocol, we excluded from further evaluation patients 
with: (1) hypodensity on computed tomography (CT) scan with 
unknown stroke onset time; (2) acute intracranial hemorrhage 
(ICH) on baseline CT examination; (3) history of ICH or subarach-
noid hemorrhage; (4) history of intracerebral malignancy; (5) ab-
sent temporal windows on pre-bolus transcranial Doppler (TCD) 
examination; (6) pre-treatment systolic blood pressure equal or 
more than 185 mm Hg or diastolic blood pressure equal or more 
than 110 mm Hg not responding to antihypertensive therapy; (7) 
other standard institutional or regional contra-indications to in-
travenous thrombolysis (IVT); (8) patient or substitute decision-
maker refusal to give informed consent to participate in the 
study; (9) patients treated directly with endovascular therapies 
(without receiving tissue plasminogen activator [tPA] preatrea-
ment); and (10) patients in whom tPA was initiated in other set-
tings before being transferred to the participating in the current 
study institutions (“drip and ship” patients). Concomitant severe 
stenosis or occlusion of the proximal internal carotid artery (ICA), 
established by either carotid duplex ultrasonography, magnetic 
resonance angiography, CT angiography, or digital subtraction 
angiography of the neck vessels was not an exclusion criterion 
and did not preclude patient enrollment into the study as long as 
patient has proximal intracranial occlusion on their baseline di-
agnostic TCD. 
Arterial occlusion at baseline TCD assessment was defined as 
residual thrombolysis in brain ischemia (TIBI) flow grades 0–3, 
complete recanalization was diagnosed if flow improved to TIBI 
grades 4–5 and partial recanalization was identified if flow im-
proved by one grade or more from the baseline but not to 
grades 4–5 on the TIBI scale. Patients with re-occlusion follow-
ing IVT were diagnosed, if after an improvement by at least one 
TIBI flow grade during TCD monitoring the residual flow wors-
ens and an arterial occlusion is diagnosed at the end of moni-
toring with TIBI grades 0–3. In patients with concomitant and 
persisting severe stenosis or occlusion of the proximal ICA, 
complete recanalization of the middle cerebral artery (MCA) 
was considered if TCD showed low-resistance waveforms (TIBI 
2 or greater) over both M1 and M2 segments, with an im-
provement in mean flow velocity to more than 20 cm/seconds. 
The following baseline characteristics were included as can-
didate variables in logistic regression models: age (per 1-year 
increase), male sex, National Institutes of Health Stroke Scale 
score (per 1-point increase), hypertension, diabetes mellitus, 
atrial fibrillation, hypercholesterolemia, coronary artery disease, 
baseline TIBI score 0–1, isolated ICA or tandem ICA/MCA oc-
clusion, systolic blood pressure before tPA-bolus (per 10 mm 
Hg increase), diastolic blood pressure before tPA-bolus (per 10 
mm Hg increase), mean serum glucose before tPA-bolus (per 
10 mg/dL increase), endovascular reperfusion therapies (intra-
arterial thrombolysis and/or mechanical thrombectomy), time 
from symptom onset to tPA-bolus (per 10-minute increase), 
and early (within 1-hour from tPA-bolus) recanalization. The 
variables that were significantly (P<0.05) associated with the 
outcome events in the univariable analyses were selected for 
inclusion in the multivariable models.
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Supplementary Table 1. Outcome definitions from the transcranial Doppler monitoring
Outcome variable Definition
Early recanalization Complete or partial recanalization within the first 60 minutes following tPA-bolus
Delayed recanalization Complete or partial recanalization within the time interval between 60–120 minutes following tPA-bolus
Sustained recanalization Complete or partial recanalization at 120 minutes following tPA-bolus
Persisting occlusion Lack of any recanalization within 120 minutes following tPA-bolus
Timing of recanalization Elapsed time between symptom onset to beginning of recanalization
Beginning of recanalization The time point that at least 1 point improvement in TIBI score is noticed during the TCD monitoring
 tPA, tissue plasminogen activator; TIBI, thrombolysis in brain ischemia; TCD, transcranial Doppler.
Supplementary Table 2. Baseline characteristics of the whole study population (n=480) 
Variable Value
Age (yr) 66±15
Male sex 289 (60)
NIHSS-score (points) 15 (10–19)
Hypertension 325 (70)
Diabetes mellitus 116 (24)
Atrial fibrillation 145 (30)
Hypercholesterolemia 186 (39)
Coronary artery disease 119 (25)
Baseline TIBI score 0–1 251 (52)
Isolated ICA or tandem ICA/MCA occlusion 68 (14)
Systolic blood pressure before tPA-bolus (mm Hg) 157±26
Diastolic blood pressure before tPA-bolus (mm Hg) 87±16
Serum glucose before tPA-bolus (mg/dL) 133±51
Time from symptom onset to tPA-bolus (min) 140 (116–170)
Endovascular reperfusion therapy 12 (2)
Values are presented as mean±standard deviation, number (%), or median (interquartile range).
NIHSS, National Institutes of Health Stroke Scale; TIBI, thrombolysis in brain ischemia; ICA, internal carotid artery; MCA, middle cerebral artery; tPA, tissue 
plasminogen activator.
Vol. 22 / No. 1 / January 2020
https://doi.org/10.5853/jos.2019.01648 http://j-stroke.org 3
Supplementary Table 3. Baseline characteristics and outcomes of study population (n=480) according to recanalization status during the 2-hour TCD-moni-
toring
Variable






Age (yr) 64±14 69±15 <0.001*
Male sex 196 (65) 93 (52) 0.005†
NIHSS-score (point) 14 (9–19) 16 (10–20) 0.013*
Hypertension 196 (65) 129 (73) 0.096†
Diabetes mellitus 68 (23) 48 (27) 0.280†
Atrial fibrillation 87 (29) 58 (32) 0.420†
Hypercholesterolemia 126 (42) 60 (35) 0.123†
Coronary artery disease 78 (26) 41 (23) 0.460†
Baseline TIBI score 0–1 155 (52) 96 (54) 0.650†
Isolated ICA or tandem ICA/MCA occlusion 30 (10) 38 (21) 0.001†
Systolic blood pressure before tPA-bolus (mm Hg) 159±26 154±27 0.085*
Diastolic blood pressure before tPA-bolus (mm Hg) 89±15 85±16 0.001*
Serum glucose before tPA-bolus (mg/dL) 130±52 136±48 0.104*
Time from symptom onset to tPA-bolus (min) 135 (113–168) 145 (120–172) 0.138*
Endovascular reperfusion therapy 6 (2) 6 (3) 0.356†
Outcome
Symptomatic intracerebral hemorrhage 8 (3) 11 (6) 0.058†
Dramatic clinical recovery at 2-hr‡ 143 (50) 7 (4) <0.001†
Dramatic clinical recovery at 24-hr§ 181 (61) 20 (12) <0.001∥
3-mo favorable functional outcome, mRS 0–1 199 (66) 33 (18) <0.001†
3-mo functional independence, mRS 0–2 238 (79) 54 (30) <0.001†
3-mo mortality 19 (6) 36 (20) <0.001†
3-mo mRS score 1 (0–2) 4 (2–5) <0.001¶
Values are presented as mean±standard deviation, number (%), or median (interquartile range).
TCD, transcranial Doppler; NIHSS, National Institutes of Health Stroke Scale; TIBI, thrombolysis in brain ischemia, ICA, internal carotid artery; MCA, middle ce-
rebral artery; tPA, tissue plasminogen activator; mRS, modified Rankin Scale.
*P-value derived from Mann-Whitney-Wilcoxon test for independent samples; †P-value derived from Pearson’s chi-square test; ‡Missing data on 2-hour NI-
HSS for 27 patients; §Missing data on 24-hour NIHSS for 24 patients; ∥P-value derived from Fisher’s exact test; ¶P-value derived from Cochran–Mantel–
Haenszel test.
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Supplementary Table 4. Baseline characteristics and outcomes of patients with middle cerebral artery occlusion (n=374) according to early recanalization 
status achieved during the first hour of TCD-monitoring
Variable
Early complete or partial recanalization 
(n=195)




Age (yr) 63±14 69±15 <0.001*
Male sex 125 (64) 92 (52) 0.015†
NIHSS-score (point) 13 (9–18) 14 (9–18) 0.625*
Hypertension 128 (66) 121 (68) 0.632†
Diabetes mellitus 43 (22) 39 (22) 0.867†
Atrial fibrillation 54 (28) 63 (35) 0.174†
Hypercholesterolemia 81 (41) 49 (28) 0.008†
Coronary artery disease 51 (26) 42 (24) 0.548†
Baseline TIBI score 0–1 103 (53) 74 (41) 0.026†
Systolic blood pressure before tPA-bolus (mm Hg) 160±26 150±25 <0.001*
Diastolic blood pressure before tPA-bolus (mm Hg) 90±15 83±15 <0.001*
Serum glucose before tPA-bolus (mg/dL) 129±55 133±47 0.532*
Time from symptom onset to tPA-bolus (min) 135 (110–160) 145 (120–180) 0.008*
Endovascular reperfusion therapies 3 (2) 3 (2) 0.916‡
Outcome
Symptomatic intracerebral hemorrhage 5 (3) 12 (7) 0.055 †
Dramatic clinical recovery at 2-hr§ 98 (53) 19 (11) <0.001†
Dramatic clinical recovery at 24-hr∥ 123 (64) 37 (23) <0.001†
3-mo favorable functional outcome, mRS 0–1 136 (70) 54 (30) <0.001†
3-mo functional independence, mRS 0–2 164 (84) 78 (44) <0.001†
3-mo mortality 10 (5) 27 (15) <0.001†
3-mo mRS score 1 (0–2) 3 (1–5) <0.001¶
Values are presented as mean±standard deviation, number (%), or median (interquartile range).
TCD, transcranial Doppler; NIHSS, National Institutes of Health Stroke Scale; TIBI, thrombolysis in brain ischemia, tPA, tissue plasminogen activator; mRS, 
modified Rankin Scale.
*P-value derived from Mann-Whitney-Wilcoxon test for independent samples; †P-value derived from Pearson’s chi-square; ‡P-value derived from Fisher’s ex-
act test; §Missing data on 2-hour NIHSS for 23 patients; ∥Missing data on 24-hour NIHSS for 19 patients; ¶P-value derived from Cochran–Mantel–Haenszel 
test. 
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Supplementary Table 5. Association of elapsed time between symptom onset and beginning of recanalization with 3-month favorable functional outcome 
in patients with sustained complete or partial recanalization at the end of TCD-monitoring (n=301)
Variable
Univariable analysis Multivariable analysis
Odds ratio (95% CI) P Odds ratio (95% CI) P
Age (/1 yr increase) 0.96 (0.94–0.98) <0.001 0.97 (0.95–0.99) 0.007
Male sex 1.24 (0.75–2.03) 0.399 -
NIHSS-score (/1 point increase) 0.86 (0.82–0.90) <0.001 0.87 (0.82–0.91) <0.001
Hypertension 0.75 (0.45–1.25) 0.265 -
Diabetes mellitus 1.01 (0.57–1.79) 0.972 -
Atrial fibrillation 0.64 (0.38–1.07) 0.086 -
Hypercholesterolemia 0.93 (0.57–1.51) 0.775 -
Coronary artery disease 0.83 (0.48–1.42) 0.491 -
Baseline TIBI score 0–1 0.61 (0.37–0.99) 0.044 1.27 (0.70–2.31) 0.431
Isolate ICA or tandem ICA/MCA occlusion 0.35 (0.16–0.76) 0.007 0.56 (0.23–1.35) 0.194
Systolic blood pressure before tPA-bolus (/10 mm Hg increase) 0.92 (0.83–1.01) 0.066 -
Diastolic blood pressure before tPA-bolus (/10 mm Hg increase) 0.84 (0.71–1.00) 0.050 -
Mean serum glucose before tPA-bolus (/10 mg/dL increase) 0.98 (0.94–1.03) 0.387 -
Time from symptom onset to tPA-bolus (/10 min increase) 0.95 (0.90–1.00) 0.052 -
Endovascular reperfusion therapies 2.60 (0.30–22.58) 0.385
Time from symptom onset to beginning of recanalization (/30 min 
increase)
0.83 (0.73–0.94) 0.003 0.84 (0.73–0.97) 0.015
TCD, transcranial Doppler; CI, confidence interval; NIHSS, National Institutes of Health Stroke Scale; TIBI, thrombolysis in brain ischemia; ICA, internal carotid 
artery; MCA, middle cerebral artery; tPA, tissue plasminogen activator.
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Supplementary Table 6. Association of baseline characteristics with the elapsed time between tPA-bolus and start of recanalization in patients with sus-
tained complete or partial recanalization at the end of TCD-monitoring (n=301)
Variable
Univariable analysis Multivariable analysis
Unstandardized linear  
regression coefficient (95% CI)
P
Unstandardized linear  
regression coefficient (95% CI)
P
Age (/1 yr increase) 0.19 (–0.02 to 0.41) 0.080 - -
Male sex –0.78 (–7.32 to 5.77) 0.816 - -
NIHSS-score (/1 point increase) –0.02 (–0.50 to 0.45) 0.924 - -
Hypertension 1.82 (–4.72 to 8.36) 0.585 - -
Diabetes mellitus –3.13 (–10.56 to 4.29) 0.407 - -
Atrial fibrillation 3.50 (–3.37 to 10.37) 0.317 - -
Hypercholesterolemia –1.54 (–7.86 to 4.78) 0.632 - -
Coronary artery disease –0.31 (–7.41 to 6.78) 0.931 - -
Baseline TIBI score 0–1 –2.30 (–8.53 to 3.92) 0.467 - -
Isolate ICA or tandem ICA/MCA occlusion 7.52 (–2.82 to 17.86) 0.153 - -
Systolic blood pressure before tPA-bolus (/10 mm Hg increase) –0.60 (–1.70 to 0.60) 0.351 - -
Diastolic blood pressure before tPA-bolus (/10 mm Hg increase) –0.40 (–2.50 to 1.70) 0.719 - -
Mean serum glucose before tPA-bolus (/10 mg/dL increase) 0.36 (–0.22 to 0.96) 0.225 - -
Endovascular reperfusion therapies 7.57 (–10.73 to 25.87) 0.416 - -
Elapsed time between stroke onset and tPA-bolus (min) 0.13 (0.06 to 0.19) <0.001 0.13 (0.06 to 0.19) <0.001
tPA, tissue plasminogen activator; TCD, transcranial Doppler; CI, confidence interval; NIHSS, National Institutes of Health Stroke Scale; TIBI, thrombolysis in 
brain ischemia; ICA, internal carotid artery; MCA, middle cerebral artery.
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Supplementary Table 7. Association of elapsed time between symptom onset and beginning of recanalization with symptomatic intracranial hemorrhage in 
the study population (n=480)
Variable
Univariable analysis Multivariable analysis
Odds ratio (95% CI) P Odds ratio (95% CI) P
Age (/1 yr increase) 1.02 (0.99–1.05) 0.219 -
Male sex 2.55 (0.83–7.79) 0.102 -
NIHSS-score (per 1 point increase) 1.06 (0.99–1.14) 0.084 -
Hypertension 0.81 (0.31–2.09) 0.656 -
Diabetes mellitus 1.88 (0.72–4.89) 0.196 -
Atrial fibrillation 1.07 (0.40–2.87) 0.894 -
Hypercholesterolemia 0.18 (0.04–0.81) 0.026 0.11 (0.02–0.62) 0.012
Coronary artery disease 0.80 (0.26–2.47) 0.701 -
Baseline TIBI score 0–1 2.03 (0.76–5.43) 0.159 -
Isolate ICA or tandem ICA/MCA occlusion 0.33 (0.04–2.49) 0.280 -
Systolic blood pressure before tPA-bolus (/10 mm Hg increase) 1.08 (0.90–1.29) 0.400 -
Diastolic blood pressure before tPA-bolus (/10 mm Hg increase) 1.01 (0.75–1.37) 0.929 -
Mean serum glucose before tPA-bolus (/10 mg/dL increase) 1.10 (1.04–1.17) 0.002 1.14 (1.06–1.22) <0.001
Time from symptom onset to tPA-bolus (/10 min increase) 1.08 (0.98–1.19) 0.103 -
Endovascular reperfusion therapies 2.27 (0.28–18.57) 0.444 - -
Time from symptom onset to beginning of recanalization
Persisting occlusion (reference category) ≤178 min 0.42 (0.13–1.34) 0.142 -
Persisting occlusion (reference category) >178 min 0.42 (0.13–1.36) 0.149 -
CI, confidence interval; NIHSS, National Institutes of Health Stroke Scale; TIBI, thrombolysis in brain ischemia; ICA, internal carotid artery; MCA, middle cere-
bral artery; tPA, tissue plasminogen activator.
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Supplementary Table 8. Association of elapsed time between symptom onset and beginning of recanalization with symptomatic intracranial hemorrhage in 
patients with sustained complete or partial recanalization at the end of TCD-monitoring (n=301)* 
Variable
Univariable analysis
Odds ratio (95% CI) P
Age (/1 yr increase) 1.03 (0.98–1.09) 0.244
Male sex 3.87 (0.47–31.91) 0.208
NIHSS-score (/1 point increase) 1.09 (0.98–1.20) 0.100
Hypertension 0.88 (0.21–3.76) 0.865
Diabetes mellitus 2.10 (0.49–9.00) 0.320
Atrial fibrillation 0.81 (0.16–4.10) 0.801
Hypercholesterolemia 0.19 (0.02–1.57) 0.124
Coronary artery disease 1.74 (0.41–7.44) 0.458
Baseline TIBI score 0–1 2.88 (0.57–14.50) 0.200
Isolate ICA or tandem ICA/MCA occlusion Not estimable† >0.999‡
Systolic blood pressure before tPA-bolus (/10 mm Hg increase) 1.02 (0.78–1.33) 0.909
Diastolic blood pressure before tPA-bolus (/10 mm Hg increase) 0.96 (0.60–1.54) 0.879
Mean serum glucose before tPA-bolus (/10 mg/dL increase) 1.05 (0.95–1.16) 0.338
Time from symptom onset to tPA-bolus (/10 min increase) 1.09 (0.95–1.26) 0.231
Time from symptom onset to beginning of recanalization (/30 min increase) 1.20 (0.87–1.67) 0.270
Endovascular reperfusion therapies Not estimable† >0.999‡
TCD, transcranial Doppler; CI, confidence interval; NIHSS, National Institutes of Health Stroke Scale; TIBI, thrombolysis in brain ischemia; ICA, internal carotid 
artery; MCA, middle cerebral artery; tPA, tissue plasminogen activator.
*No multivariable analysis was performed as no since no significant (P<0.05) predictors were identified at the univariable analyses; †Not estimable due to lack 
of events (symptomatic intracranial hemorrhage) in the subgroups of patients with isolate ICA or tandem ICA/MCA occlusion or those receiving endovascular 
treatment; ‡P-value derived from Fisher’s exact test.
Vol. 22 / No. 1 / January 2020
https://doi.org/10.5853/jos.2019.01648 http://j-stroke.org 9
Supplementary Table 9. Association of elapsed time between symptom onset and beginning of recanalization with 3-month mortality in patients with sus-
tained complete or partial recanalization at the end of TCD-monitoring (n=301)
Variable
Univariable analysis Multivariable analysis
Odds ratio (95% CI) P Odds ratio (95% CI) P
Age (/1 yr increase) 1.11 (1.05–1.16) <0.001 1.08 (1.03–1.14) 0.003
Male sex 0.92 (0.35–2.41) 0.862 -
NIHSS-score (/1 point increase) 1.21 (1.12–1.31) <0.001 1.18 (1.08–1.28) <0.001
Hypertension 0.71 (0.28–1.83) 0.483 -
Diabetes mellitus 1.63 (0.60–4.47) 0.342 -
Atrial fibrillation 1.47 (0.56–3.86) 0.439 -
Hypercholesterolemia 0.79 (0.30–2.08) 0.638 -
Coronary artery disease 2.77 (1.08–7.08) 0.034 2.35 (0.82–6.75) 0.114
Baseline TIBI score 0–1 1.31 (0.51–3.35) 0.576 -
Isolate ICA or tandem ICA/MCA occlusion 2.62 (0.81–8.46) 0.109 -
Systolic blood pressure before tPA-bolus (/10 mm Hg increase) 0.92 (0.77–1.10) 0.364 -
Diastolic blood pressure before tPA-bolus (/10 mm Hg increase) 0.94 (0.68–1.30) 0.692 -
Mean serum glucose before tPA-bolus (/10 mg/dL increase) 1.01 (0.92–1.10) 0.884 -
Time from symptom onset to tPA-bolus (/10 min increase) 0.99 (0.90–1.10) 0.871 -
Time from symptom onset to beginning of recanalization (/30 min  
increase)
1.00 (0.79–1.27) 0.994 -
Endovascular reperfusion therapies Not estimable* >0.999† -
TCD, transcranial Doppler; CI, confidence interval; NIHSS, National Institutes of Health Stroke Scale; TIBI, thrombolysis in brain ischemia; ICA, internal carotid 
artery; MCA, middle cerebral artery; tPA, tissue plasminogen activator.
*Not estimable due to lack of events (deaths) in the subgroup of patients receiving endovascular treatment; †P-value derived from Fisher’s exact test.
